UNSPSC 85613221: Supplement accessory pancreatic duct with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement accessory pancreatic duct with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FUF47Z

UNSPSC 85613221 Supplement accessory pancreatic duct with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that describes a specific surgical procedure. However, the recent state and local contract opportunities tagged under this code do not involve pancreatic duct procedures or surgical implants. Instead, the opportunities reflect a mismatch between the nominal UNSPSC taxonomy and the work actually being solicited: the tagged records cover occupational medical surveillance, disability medical evaluations, pharmacy benefit management, surgical benefit carve-out programs, temporary health professional staffing, and youth detention healthcare services. None of these activities align with the code's stated scope of pancreatic tissue supplementation. The code shows little relevant recent procurement activity under its intended commodity definition.

Given the clear disconnect between the code name and the actual opportunities posted, this Commodity code does not represent a viable pursuit area for vendors specializing in pancreatic surgical procedures or related implant devices. Firms monitoring state and local procurement should flag this code as either misconfigured in the taxonomy system or as indicating very limited actual demand for the named procedure. The geographic spread of the misaligned opportunities—Arizona, California, Washington, Texas, and Florida—does not support a coherent market signal under the intended scope.